Tianjin Pharma DRT (SH600329)
Group Profile
Heritage of Ingenuity
Group News
Health Self-Check
Health Guide
中文
中文
English
search
Group Profile
Group Introduction
History
Corporate Culture
Group Industry
ESG
Brand Display
Heritage of Ingenuity
Heritage of Ingenuity
Product Center
Product Family
Products and Services
Group News
Group News
Health Guide
Health Information
Media Coverage
Investor Relations
Stock Information
Company Announcements
Investor Contact
集团党建
党建新闻
执纪监督
Join Us
Talent Concept
Recruitment Information
Contact Us
Contact Us
Tianjin Pharma DRT (SH600329)
35.17
+0.35 +1.01%
中文
English
Home Page
Group Profile
Group Introduction
History
Corporate Culture
Group Industry
ESG
Brand Display
Heritage of Ingenuity
Product Center
Product Family
Products and Services
Group News
Health Guide
Health Information
Media Coverage
Investor Relations
Stock Information
Company Announcements
Investor Contact
集团党建
党建新闻
执纪监督
Join Us
Talent Concept
Recruitment Information
Contact Us
Online Mall
Back
Home Page
Group News
Content
新华社重磅关注达仁堂：古老中医药为国际健康产业"开新方"
2026 / 02 / 27
了解更多产品信息
欢迎点击进入
达仁堂官方小程序
往期回顾
新华社关注：古老中医药为国际健康产业“开新方”
聚焦CAP治疗 清肺消炎丸获《指南》权威推荐
实干开局！达仁堂织密海外零售网络 国际化按下“加速键”
达仁堂策马扬鞭启新程！
“数”写新篇！津药达仁堂启动实验室信息化管理系统建设
Previous：
中国日报关注达仁堂：百年中医药老字号转型成为时尚养生品牌
Next：
锚定质量新高地 擘画创新未来——天津市中药质量控制重点实验室学术委员会会议召开
We are the Leader of Chinese Medicine and Striving to Become a Leader in Innovative Medicine in China
Home Page
>
Group News
>
Content
